{"id":"https://openalex.org/W2890705485","doi":"https://doi.org/10.1200/jco.2017.35.15_suppl.8029","title":"HDAC11 as a candidate therapeutic target in multiple myeloma.","display_name":"HDAC11 as a candidate therapeutic target in multiple myeloma.","publication_year":2017,"publication_date":"2017-05-20","ids":{"openalex":"https://openalex.org/W2890705485","doi":"https://doi.org/10.1200/jco.2017.35.15_suppl.8029","mag":"2890705485"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2017.35.15_suppl.8029","doi":"https://doi.org/10.1200/jco.2017.35.15_suppl.8029","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2017.35.15_suppl.8029","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110321410","display_name":"Allison Distler","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Allison Distler","raw_affiliation_strings":["H. Lee Moffitt Cancer Center, Tampa, FL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H. Lee Moffitt Cancer Center, Tampa, FL;","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064581434","display_name":"Jason B. Brayer","orcid":"https://orcid.org/0000-0003-1126-2279","observed_orcids":["https://orcid.org/0000-0003-1126-2279"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jason B. Brayer","raw_affiliation_strings":["H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL;","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014350127","display_name":"Mark B. Meads","orcid":"https://orcid.org/0009-0008-0259-1875","observed_orcids":["https://orcid.org/0009-0008-0259-1875"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mark Meads","raw_affiliation_strings":["H. Lee Moffitt Cancer Center, Tampa, FL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H. Lee Moffitt Cancer Center, Tampa, FL;","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085814876","display_name":"Eva Sahakian","orcid":"https://orcid.org/0000-0001-6930-2275","observed_orcids":["https://orcid.org/0000-0001-6930-2275"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eva Sahakian","raw_affiliation_strings":["H. Lee Moffitt Cancer Center, Tampa, FL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H. Lee Moffitt Cancer Center, Tampa, FL;","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035905546","display_name":"John Joseph Powers","orcid":"https://orcid.org/0000-0003-3800-2645","observed_orcids":["https://orcid.org/0000-0003-3800-2645"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John Joseph Powers","raw_affiliation_strings":["H. Lee Moffitt Cancer Canter and Research Institute, Tampa, FL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H. Lee Moffitt Cancer Canter and Research Institute, Tampa, FL;","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087799564","display_name":"Melissa Alsina","orcid":"https://orcid.org/0000-0003-4946-823X","observed_orcids":["https://orcid.org/0000-0003-4946-823X"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Melissa Alsina","raw_affiliation_strings":["Moffitt Cancer Center, Tampa, FL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Moffitt Cancer Center, Tampa, FL;","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062691289","display_name":"Taiga Nishihori","orcid":"https://orcid.org/0000-0002-2621-7924","observed_orcids":["https://orcid.org/0000-0002-2621-7924"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Taiga Nishihori","raw_affiliation_strings":["Moffitt Cancer Center, Tampa, FL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Moffitt Cancer Center, Tampa, FL;","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077110117","display_name":"Rachid Baz","orcid":"https://orcid.org/0000-0003-4538-4733","observed_orcids":["https://orcid.org/0000-0003-4538-4733"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rachid C. Baz","raw_affiliation_strings":["Moffitt Cancer Center, Tampa, FL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Moffitt Cancer Center, Tampa, FL;","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101811382","display_name":"Javier A. Pinilla-Ibarz","orcid":"https://orcid.org/0000-0003-3170-9648","observed_orcids":["https://orcid.org/0000-0003-3170-9648"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Javier Pinilla-Ibarz","raw_affiliation_strings":["H. Lee Moffitt Cancer Canter and Research Institute, Tampa, FL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H. Lee Moffitt Cancer Canter and Research Institute, Tampa, FL;","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108222207","display_name":"Eduardo M. Sotomayor","orcid":"https://orcid.org/0009-0009-5081-3855","observed_orcids":["https://orcid.org/0009-0009-5081-3855"]},"institutions":[{"id":"https://openalex.org/I193531525","display_name":"George Washington University","ror":"https://ror.org/00y4zzh67","country_code":"US","type":"education","lineage":["https://openalex.org/I193531525"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eduardo M. Sotomayor","raw_affiliation_strings":["George Wasington University, Washington, DC;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"George Wasington University, Washington, DC;","institution_ids":["https://openalex.org/I193531525"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5053572690","display_name":"Kenneth H. Shain","orcid":"https://orcid.org/0000-0003-4178-8888","observed_orcids":["https://orcid.org/0000-0003-4178-8888"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kenneth H. Shain","raw_affiliation_strings":["Moffitt Cancer Center, Tampa, FL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Moffitt Cancer Center, Tampa, FL;","institution_ids":["https://openalex.org/I3019308854"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"35","issue":"15_suppl","first_page":"8029","last_page":"8029"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.7875999808311462,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.7875999808311462,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11736","display_name":"Histone Deacetylase Inhibitors Research","score":0.20800000429153442,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":0.9769999980926514},{"id":"https://openalex.org/keywords/histone-deacetylase-inhibitors","display_name":"histone deacetylase inhibitors","score":0.9259999990463257},{"id":"https://openalex.org/keywords/quisinostat","display_name":"quisinostat","score":0.9980000257492065},{"id":"https://openalex.org/keywords/irf4","display_name":"IRF4","score":0.9229999780654907},{"id":"https://openalex.org/keywords/b-cell-development","display_name":"B cell development","score":0.6050000190734863},{"id":"https://openalex.org/keywords/plasma-cell-differentiation","display_name":"plasma cell differentiation","score":0.5899999737739563},{"id":"https://openalex.org/keywords/proteasome-inhibitor-resistance","display_name":"proteasome inhibitor resistance","score":0.8399999737739563},{"id":"https://openalex.org/keywords/bortezomib","display_name":"bortezomib","score":0.9120000004768372},{"id":"https://openalex.org/keywords/carfilzomib","display_name":"carfilzomib","score":0.9950000047683716},{"id":"https://openalex.org/keywords/drug-synergy","display_name":"drug synergy","score":0.6110000014305115},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.5339999794960022},{"id":"https://openalex.org/keywords/therapeutic-target","display_name":"therapeutic target","score":0.7799999713897705},{"id":"https://openalex.org/keywords/sirna-knockdown","display_name":"siRNA knockdown","score":0.7149999737739563}],"concepts":[{"id":"https://openalex.org/C4951695","wikidata":"https://www.wikidata.org/wiki/Q18046437","display_name":"HDAC11","level":5,"score":0.7315714359283447},{"id":"https://openalex.org/C2780108899","wikidata":"https://www.wikidata.org/wiki/Q15366934","display_name":"Carfilzomib","level":4,"score":0.679189920425415},{"id":"https://openalex.org/C2780225316","wikidata":"https://www.wikidata.org/wiki/Q7131441","display_name":"Panobinostat","level":5,"score":0.6498544812202454},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5463436841964722},{"id":"https://openalex.org/C2777478702","wikidata":"https://www.wikidata.org/wiki/Q419319","display_name":"Bortezomib","level":3,"score":0.49051350355148315},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.47336480021476746},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.4604490399360657},{"id":"https://openalex.org/C2776243700","wikidata":"https://www.wikidata.org/wiki/Q7252869","display_name":"Proximity ligation assay","level":3,"score":0.45734095573425293},{"id":"https://openalex.org/C2778367456","wikidata":"https://www.wikidata.org/wiki/Q7251235","display_name":"Proteasome inhibitor","level":3,"score":0.45402365922927856},{"id":"https://openalex.org/C79904392","wikidata":"https://www.wikidata.org/wiki/Q5976738","display_name":"Lymphopoiesis","level":4,"score":0.4460238516330719},{"id":"https://openalex.org/C2781378782","wikidata":"https://www.wikidata.org/wiki/Q96372211","display_name":"Antipain","level":5,"score":0.4434874355792999},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.4423344135284424},{"id":"https://openalex.org/C53227056","wikidata":"https://www.wikidata.org/wiki/Q189152","display_name":"Viability assay","level":3,"score":0.4356253147125244},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.4167674481868744},{"id":"https://openalex.org/C2778305200","wikidata":"https://www.wikidata.org/wiki/Q174378","display_name":"Histone deacetylase","level":4,"score":0.3497849702835083},{"id":"https://openalex.org/C64927066","wikidata":"https://www.wikidata.org/wiki/Q36293","display_name":"Histone","level":3,"score":0.3198045492172241},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.29066914319992065},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.263194739818573},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.11231130361557007},{"id":"https://openalex.org/C109159458","wikidata":"https://www.wikidata.org/wiki/Q919283","display_name":"Haematopoiesis","level":3,"score":0.11056113243103027},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.08218374848365784},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.08027034997940063},{"id":"https://openalex.org/C2775883766","wikidata":"https://www.wikidata.org/wiki/Q11350119","display_name":"Leupeptin","level":4,"score":0.07517856359481812},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.07516738772392273},{"id":"https://openalex.org/C2776714187","wikidata":"https://www.wikidata.org/wiki/Q212410","display_name":"Protease","level":3,"score":0.0},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.0},{"id":"https://openalex.org/C28328180","wikidata":"https://www.wikidata.org/wiki/Q48196","display_name":"Stem cell","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2017.35.15_suppl.8029","doi":"https://doi.org/10.1200/jco.2017.35.15_suppl.8029","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2017.35.15_suppl.8029","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9940000176429749,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3035915189","https://openalex.org/W2575953974","https://openalex.org/W3214304478","https://openalex.org/W2914455248","https://openalex.org/W2954797611","https://openalex.org/W2292597627","https://openalex.org/W2987858135","https://openalex.org/W2920863831","https://openalex.org/W2055588591","https://openalex.org/W1997576097"],"abstract_inverted_index":{"8029":[0],"Background:":[1],"Histone":[2],"deacetylase":[3],"(HDAC)":[4],"inhibitors":[5],"(HDI)":[6],"have":[7],"a":[8,251,268,299,309],"therapeutic":[9,35,42],"niche":[10],"in":[11,27,33,65,87,130,148,152,160,165,185,202,209,234,274,292],"multiple":[12],"myeloma":[13],"(MM)":[14],"due":[15],"to":[16,19,72,84,219],"their":[17],"ability":[18],"salvage":[20],"proteasome":[21],"inhibitor":[22],"and":[23,60,79,101,111,156,199,239,256,264,304,315],"immunomodulatory":[24],"drug":[25],"responsiveness":[26],"refractory":[28],"patients,":[29],"thus":[30],"raising":[31],"interest":[32],"this":[34,306],"class.":[36],"Selective":[37],"HDI":[38,110,177],"may":[39],"further":[40],"improve":[41],"efficacy.":[43],"Methods:":[44],"B":[45,74,140,166],"cell":[46,75,90,141,188,213,248,290],"lymphopoiesis":[47],"was":[48,93,194,207,278],"evaluated":[49],"using":[50],"Tg-HDAC11-eGFP":[51,133],"mice":[52,134],"expressing":[53],"eGFP":[54,128],"regulated":[55],"by":[56,95,109,121,242,280],"the":[57,73,114,153,210],"HDAC11":[58,66,86,136,145,180,233,255,286,303],"promoter":[59],"congenic":[61],"mouse":[62],"strains":[63],"deficient":[64],"expression":[67],"globally":[68],"(B6.HDAC11-/-)":[69],"or":[70],"targeted":[71],"lineage":[76],"(CD19Cre.HDAC11-/-).":[77],"Molecular":[78],"pharmacologic":[80],"means":[81],"were":[82,119],"used":[83],"impair":[85],"established":[88],"MM":[89,187,247,265,289,316],"lines.":[91],"Viability":[92],"measured":[94],"activated":[96,237],"caspase-3,":[97],"Annexin/PI":[98],"(A/PI)":[99],"staining,":[100],"CCK-8":[102],"viability":[103,241],"assay.":[104],"Subcellular":[105],"localization":[106],"changes":[107],"induced":[108],"identification":[112],"of":[113,132,216,223,232,246,261],"novel":[115,252],"binding":[116,300],"partner":[117,301],"IRF4":[118,297],"assessed":[120],"proximity":[122],"ligation":[123],"assay":[124],"(PLA).":[125],"Results:":[126],"Profound":[127],"increases":[129],"PC":[131,151,158,262,313],"suggest":[135],"influences":[137],"late":[138],"stage":[139],"development.":[142],"In":[143],"addition,":[144],"deficiency":[146],"results":[147],"dramatically":[149],"reduced":[150,240],"bone":[154],"marrow":[155],"periphery.":[157],"depletion":[159],"CD19Cre.HDAC11-/-mice":[161],"suggests":[162],"activity":[163,193],"inherent":[164],"cells":[167,218,236],"rather":[168],"than":[169],"via":[170],"externally":[171],"derived":[172],"signals.":[173],"Quisinostat":[174],"(QS),":[175],"an":[176,258],"with":[178,196],"enhanced":[179],"selectivity,":[181],"showed":[182,250],"dose-dependent":[183],"cytotoxicity":[184,273],"10":[186],"lines":[189,249],"(EC50":[190],"1-10nM).":[191],"This":[192,276],"synergistic":[195],"bortezomib":[197],"(BTZ)":[198],"carfilzomib":[200],"(CFZ)":[201],"RPMI-8226":[203,217,235],"cells,":[204],"while":[205],"synergism":[206],"amplified":[208],"BTZ-resistant":[211],"RPMI-8226-B25":[212],"line.":[214],"Exposure":[215],"QS":[220],"decreased":[221],"detection":[222],"nuclear,":[224],"but":[225],"not":[226],"cytosolic,":[227],"HDAC11.":[228],"Targeted":[229],"siRNA\u2013mediated":[230],"silencing":[231],"caspase-3":[238],"A/PI":[243],"staining.":[244],"PLA":[245],"interaction":[253,277,307],"between":[254],"IRF4,":[257],"essential":[259],"regulator":[260],"differentiation":[263],"survival,":[266],"unmasking":[267],"potential":[269],"mechanism":[270,311],"for":[271,302],"HDAC11-induced":[272],"MM.":[275],"disrupted":[279],"QS.":[281],"Conclusions:":[282],"We":[283],"show":[284],"that":[285],"inhibition":[287],"reduces":[288],"survival":[291],"vitro.":[293],"Furthermore,":[294],"we":[295],"identify":[296],"as":[298,308],"propose":[305],"candidate":[310],"regulating":[312],"maturation":[314],"survival.":[317]},"counts_by_year":[{"year":2019,"cited_by_count":1}],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2018-09-27T00:00:00"}